CRISPR-Cas systems are adaptive immune systems found in prokaryotes that defend against invading nucleic acids through CRISPR ...
These chains come in a wide range of lengths. In humans a typical protein is about 400 amino acids long; some are a lot longer. Molecules of RNA, one of the two nucleic acids, can reach up to 100,000 ...
The amino acid glycine is an important neurotransmitter that regulates memory, reflex, and brain development, and it may also ...
Xeno nucleic acids are essential for the development of nucleic acid-based drugs. To be effective, they need to be able to stably bind to natural RNA (a cellular single-stranded version of the DNA, ...
Scientists are exploring how RNA might have jump-started life four billion years ago and how it's now advancing drug ...
Earth’s most diverse biological entities are the viruses that infect bacteria, called bacteriophages (phages). They are rich ...
In our "EXplained" video series, we present the seven Clusters of Excellence with which our university is entering the next funding phase of the ...
Although zinc fingers are best known to interact with DNA, they can, as in the case of the TFIIIA protein, also interact with RNA. A recent crystal structure reveals that zinc fingers can take ...
Developments in molecular diagnostics have been vital in discovering novel pathogens and diagnosing many human diseases. The recent coronavirus 2019 (COVID-19) pandemic, caused by severe acute ...
PLEASANTON, Calif.--(BUSINESS WIRE)--GenTegra LLC, an innovator of complete sample protection for biological research, announced today the launch of RNAdvantage, the latest addition to their suite of ...
To obtain high-quality, purified nucleic acids, scientists can use several different methods, including phenol-chloroform extraction, cesium chloride/ethidium bromide (CsCl/EtBr) gradient ...
As medical research progresses, traditional treatment protocols are being rapidly exhausted. New approaches to treat diseases that do not respond to conventional drugs are the need of the hour. In ...